Concepedia

Jung‐Mo Ahn

JA

Statistics

Publications

47

Citations

2.5K

H-Index

27

Active since

1994

Affiliations

The University of Texas at Dallas(Current)

The University of Texas Southwestern Medical Center

Kyungpook National University

University of Arizona

Jung‐Mo Ahn is an author at The University of Texas at Dallas specializing in molecular oncology, life sciences, and medicine.

ORCID

Publications per year

1994–2022

47

Publications

47

Peptidomimetic targeting of critical androgen receptor–coregulator interactions in prostate cancer

Preethi Ravindranathan, Tae-Kyung Lee, Lin Yang et al. · Nature Communications · 2013 · 256 citations · Full text

, , +14

Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications

Bikash Manandhar, Jung‐Mo Ahn · Journal of Medicinal Chemistry · 2014 · 194 citations · Full text

, , +17

Targeting Hypoxia-Inducible Factor-1α/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary Fibrosis

Justin Goodwin, Hyunsung Choi, Meng-Hsiung Hsieh et al. · American Journal of Respiratory Cell and Molecular Biology · 2017 · 169 citations · Full text

, , +16

The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition

Justin Goodwin, Michael L. Neugent, Shin Yup Lee et al. · Nature Communications · 2017 · 149 citations · Full text

, , +17

Mouse Spermatogenesis Requires Classical and Nonclassical Testosterone Signaling1

Corey Toocheck, Terri Clister, John A. Shupe et al. · Biology of Reproduction · 2015 · 118 citations · Full text

, , +17

1–5 of 47